Sebastian Bohn

Dr. Sebastian Bohn

Department of Ophthalmology, Rostock University Medical Center
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Biomedical Optics Express
Verified
Journal Article
Open access
PDF file
SBSebastian Bohn
Sebastian Bohn
KSKarsten Sperlich
Karsten Sperlich
SAStephan Allgeier
Stephan Allgeier
ABAndreas Bartschat
Andreas Bartschat
RPRuby Prakasam
Ruby Prakasam
OSOliver Stachs
Oliver Stachs
We present an in vivo confocal laser scanning microscopy based method for large 3D reconstruction of the cornea on a cellular level with cropped volume sizes up to 266 x 286 x 396 µm3. The microscope objective used is equipped with a piezo actuator for automated, fast and precise closed-loop focal plane control. Furthermore, we present a novel concave surface contact cap, which significantly reduces eye movements by up to 87%, hence increasing the overlapping image area of the whole stack. This increases the cuboid volume of the generated 3D reconstruction significantly. The possibility to generate oblique sections using isotropic volume stacks opens the window to slit lamp microscopy on a cellular level.

18 September 2020 in Biomedical Optics Express
Verified
Journal Article
Closed access
SBSebastian Bohn
Sebastian Bohn
KSKarsten Sperlich
Karsten Sperlich
TSThomas Stahnke
Thomas Stahnke
MSMelanie Schünemann
Melanie Schünemann
HSHeinrich Stolz
Heinrich Stolz
OSOliver Stachs
Oliver Stachs
Confocal reflectance microscopy has demonstrated the ability to produce in vivo images of corneal tissue with sufficient cellular resolution to diagnose a broad range of corneal conditions. To investigate the spectral behavior of corneal reflectance imaging, a modified laser ophthalmoscope was used. Imaging was performed in vivo on a human cornea as well as ex vivo on porcine and lamb corneae. Various corneal layers were imaged at the wavelengths 488 nm, 518 nm, and 815 nm and compared regarding image quality and differences in the depicted structures. Besides the wavelength- and depth-dependent scattering background, which impairs the image quality, a varying spectral reflectance of certain structures could be observed. Based on the obtained results, this paper emphasizes the importance of choosing the appropriate light source for corneal imaging. For the examination of the epithelial layers and the endothelium, shorter wavelengths should be preferred. In the remaining layers, longer wavelength light has the advantage of less scattering loss and a potentially higher subject compliance.

7 May 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
KSKatharina Sterenczak
Katharina Sterenczak
NSNadine Stache
Nadine Stache
SBSebastian Bohn
Sebastian Bohn
SAStephan Allgeier
Stephan Allgeier
BKBernd Köhler
Bernd Köhler
ASAngrit Stachs
Angrit Stachs
During breast cancer therapy, paclitaxel and trastuzumab are both associated with adverse effects such as chemotherapy-induced peripheral neuropathy and other systemic side effects including ocular complications. Corneal nerves are considered part of the peripheral nervous system and can be imaged non-invasively by confocal laser scanning microscopy (CLSM) on the cellular level. Thus, in vivo CLSM imaging of structures of the corneal subbasal nerve plexus (SNP) such as sensory nerves or dendritic cells (DCs) can be a powerful tool for the assessment of corneal complications during cancer treatment. During the present study, the SNP of a breast cancer patient was analyzed over time by using large-scale in vivo CLSM in the course of paclitaxel and trastuzumab therapy. The same corneal regions could be re-identified over time. While the subbasal nerve morphology did not alter significantly, a change in dendritic cell density and an additional local burst within the first 11 weeks of therapy was detected, indicating treatment-mediated corneal inflammatory processes. Ocular structures such as nerves and dendritic cells could represent useful biomarkers for the assessment of ocular adverse effects during cancer therapy and their management, leading to a better visual prognosis.

9 May 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
SBSebastian Bohn
Sebastian Bohn
NSNadine Stache
Nadine Stache
KSKarsten Sperlich
Karsten Sperlich
SAStephan Allgeier
Stephan Allgeier
BKBernd Köhler
Bernd Köhler
KSKatharina Sterenczak
Katharina Sterenczak
Paclitaxel and trastuzumab have been associated with adverse effects including chemotherapy-induced peripheral neuropathy (CIPN) or ocular complications. In vivo confocal laser scanning microscopy (CLSM) of the cornea could be suitable for assessing side effects since the cornea is susceptible to, i.e., neurotoxic stimuli. The study represents a one-year follow-up of a breast cancer patient including large-area in vivo CLSM of the subbasal nerve plexus (SNP), nerve function testing, and questionnaires during paclitaxel and trastuzumab therapy. Six monitoring sessions (one baseline, four during, and one after therapy) over 58 weeks were carried out. Large-area mosaics of the SNP were generated, and identical regions within all sessions were assigned. While corneal nerve morphology did not cause alterations, the number of dendritic cells (DCs) showed dynamic changes with a local burst at 11 weeks after baseline. Simultaneously, paclitaxel treatment was terminated due to side effects, which, together with DCs, returned to normal levels as the therapy progressed. Longitudinal in vivo CLSM of the SNP could complement routine examinations and be helpful to generate a comprehensive clinical picture. The applied techniques, with corneal structures acting as biomarkers could represent a diagnostic tool for the objective assessment of the severity of adverse events and the outcome.

26 April 2019 in Biomedical Optics Express
Verified
Journal Article
Closed access
PDF file
SBSebastian Bohn
Sebastian Bohn
KSKarsten Sperlich
Karsten Sperlich
HSHeinrich Stolz
Heinrich Stolz
RGRudolf F. Guthoff
Rudolf F. Guthoff
OSOliver Stachs
Oliver Stachs
In vivo corneal confocal microscopy and its operability in scientific as well as in clinical applications is often impaired by the lack of information on imaging plane position and orientation inside the cornea during patient’s examination. To overcome this hurdle, we have developed a novel corneal imaging system based on a commercial scanning device and a modified Rostock Cornea Module. The presented preliminary system produces en face images by confocal laser scanning microscopy and sagittal cross-section images by optical coherence tomography simultaneously. This enables imaging guidance during examinations, improved features for diagnostics along with thickness measurements of the cornea as well as corneal substructures from oblique sections.

21 June 2022 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
NSNadine Stache
Nadine Stache
KSKatharina A. Sterenczak
Katharina A. Sterenczak
KSKarsten Sperlich
Karsten Sperlich
CMCarl F. Marfurt
Carl F. Marfurt
SAStephan Allgeier
Stephan Allgeier
SBSebastian Bohn
Sebastian Bohn
Original Article Assessment of dynamic corneal nerve changes using static landmarks by in vivo large-area confocal microscopy—a longitudinal proof-of-concept study Nadine Stache, Katharina A. Sterenczak, Karsten Sperlich, Carl F. Marfurt, Stephan Allgeier, Bernd Köhler, Ralf Mikut, Andreas Bartschat, Klaus-Martin Reichert, Rudolf F. Guthoff, Angrit Stachs, Oliver Stachs, Sebastian Bohn